Saccharomyces boulardii is having a moment. Search interest in the UK has grown substantially in 2025 and 2026, driven by growing awareness of its unique properties — particularly for post-antibiotic gut recovery and travellers' diarrhoea. Unlike standard bacterial probiotics, S. boulardii is a probiotic yeast, and this distinction matters significantly for when and why to use it. This guide explains the difference and when S. boulardii is the right choice.
What Is Saccharomyces Boulardii?
Saccharomyces boulardii is a non-pathogenic yeast strain first isolated in 1920 by French scientist Henri Boulard from the skin of lychee and mangosteen fruit in Southeast Asia. Boulard noticed that local people chewed these fruits to alleviate symptoms of cholera — he identified S. boulardii as the active agent responsible.
As a yeast rather than a bacterium, S. boulardii has fundamentally different properties from conventional probiotic strains like Lactobacillus and Bifidobacterium. These differences make it uniquely suited to specific gut health situations.
How S. Boulardii Differs from Bacterial Probiotics
Antibiotic Resistance
This is the most clinically important distinction. Antibiotics kill bacteria — both harmful pathogens and the beneficial bacteria in your gut microbiome. Standard bacterial probiotics taken during a course of antibiotics are largely destroyed alongside the target pathogens, reducing their effectiveness to near zero during active treatment. S. boulardii, being a yeast rather than a bacterium, is completely unaffected by antibiotics. It survives the course intact and actively protects the gut environment while antibiotic-induced bacterial depletion occurs.
This is why S. boulardii is specifically recommended for concurrent use with antibiotics, not just after finishing the course — it is the only probiotic that remains active throughout treatment.
Mechanism of Action
S. boulardii works through several complementary mechanisms: it produces proteases that degrade bacterial toxins (particularly Clostridioides difficile toxins, the cause of antibiotic-associated diarrhoea), stimulates secretory IgA (gut immune defence), enhances gut barrier integrity by supporting tight junction proteins, and competitively excludes pathogenic organisms from gut wall adhesion sites.
Travellers' Diarrhoea
Multiple randomised controlled trials confirm S. boulardii significantly reduces the risk and duration of travellers' diarrhoea — the most common illness affecting UK travellers abroad. Starting supplementation 5 days before travel and continuing throughout the trip provides meaningful protection against enterotoxigenic E. coli and other common travel pathogens.
When Should You Take S. Boulardii?
- During a course of antibiotics: Start on day 1, take 2 hours away from antibiotic doses, continue for 2 weeks after the course ends to support microbiome recolonisation
- Travelling abroad: Start 5 days before departure, continue throughout the trip
- IBS-D (diarrhoea-predominant): Clinical evidence supports S. boulardii for reducing IBS-D symptom frequency and severity
- After gut illness: Following gastroenteritis or food poisoning, S. boulardii speeds restoration of gut barrier integrity
SaccharoMyTum — BioBodyBoost
SaccharoMyTum provides a clinical-dose S. boulardii culture alongside vitamin D3 for combined gut and immune support — in a halal certified, vegan HPMC capsule (no gelatin), UK-made. For antibiotic courses, take two capsules daily, spaced at least 2 hours from antibiotic doses.
After completing a course of S. boulardii, transition to a multi-strain bacterial probiotic to recolonise the full gut microbiome. BioTic 20 Billion is ideal for this phase — 20 billion CFU of diverse Lactobacillus and Bifidobacterium strains to rebuild the broad bacterial ecosystem S. boulardii has been protecting. Explore the full Gut Health UK collection.
